Research output per year
Research output per year
Personal profile
Research Interests
Anti-cancer therapeutics
Neuro oncology
Gynaecological cancers
Genitourinary cancers
Rare cancers - cancer of unknown primary, endocrine cancers and others
Supportive care
Neuro oncology
Gynaecological cancers
Genitourinary cancers
Rare cancers - cancer of unknown primary, endocrine cancers and others
Supportive care
Research Expertise
Cancer
Cancer Pharmacology
Education/Academic qualification
PhD, Flinders University
External positions
Clinical lead, Statewide Cancer Clinical Network, Commission on Excellence and Innovation in Health (CEIH)
2019 → …
SALHN, Southern Adelaide Local Health Network
Fingerprint
Dive into the research topics where Ganessan Kichenadasse is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours (British Journal of Cancer, (2021), 10.1038/s41416-021-01632-2)
Lickliter, J. D., Voskoboynik, M., Mileshkin, L., Gan, H. K., Kichenadasse, G., Zhang, K., Zhang, M., Tang, Z. & Millward, M., 1 Feb 2022, In: British Journal of Cancer. 126, 2, p. 310 1 p., 310.Research output: Contribution to journal › Comment/debate
Open AccessFile -
Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control Trials
Hopkins, A. M., Badaoui, S., Kichenadasse, G., Karapetis, C. S., McKinnon, R. A., Rowland, A. & Sorich, M. J., 17 Feb 2022, (E-pub ahead of print) In: Journal of Thoracic Oncology. 10 p.Research output: Contribution to journal › Article › peer-review
-
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150
Hopkins, A. M., Kichenadasse, G., McKinnon, R. A., Abuhelwa, A. Y., Logan, J. M., Badaoui, S., Karapetis, C. S., Rowland, A. & Sorich, M. J., 1 Jan 2022, In: British Journal of Cancer. 126, 1, p. 42-47 6 p.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus) -
Enhanced Bellmunt Risk Score for Survival Prediction in Urothelial Carcinoma Treated With Immunotherapy
Abuhelwa, A. Y., Bellmunt, J., Kichenadasse, G., McKinnon, R. A., Rowland, A., Sorich, M. J. & Hopkins, A. M., Apr 2022, In: Clinical Genitourinary Cancer. 20, 2, p. 132-138 7 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours
Lickliter, J. D., Voskoboynik, M., Mileshkin, L., Gan, H. K., Kichenadasse, G., Zhang, K., Zhang, M., Tang, Z. & Millward, M., 9 Mar 2022, In: British Journal of Cancer. 126, 4, p. 576-585 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile
Activities
- 1 Oral presentation
-
Utility of a self-management approach in lifestyle interventions for cancer survivors - preliminary findings from the NAPA trial
Sharon Lawn (Speaker), Stephanie Zrim (Speaker), Stephanie Leggett (Speaker), Michelle Miller (Speaker), L Jones (Speaker), Jim Dollman (Speaker), Sue Booth (Speaker), Richard Woodman (Speaker), Chris Karapetis (Speaker), Ganessan Kichenadasse (Speaker), Shawgi Sukumaran (Speaker) & Bogda Koczwara (Speaker)
6 Feb 2013Activity: Talk or presentation types › Oral presentation